Click Holdings Limited (NASDAQ:CLIK) Short Interest Update

Posted by Stacy Sanders on Mar 26th, 2026

Click Holdings Limited (NASDAQ:CLIK – Get Free Report) was the recipient of a significant decline in short interest in March. As of March 13th, there was short interest totaling 451 shares, a decline of 73.5% from the February 26th total of 1,704 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 196,080 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Click in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

View Our Latest Stock Report on Click

Click Stock Up 2.1%

NASDAQ CLIK opened at $1.98 on Thursday. Click has a 1-year low of $1.50 and a 1-year high of $96.00. The stock’s 50 day moving average is $3.70 and its two-hundred day moving average is $5.92.

About Click

(Get Free Report)

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.